Visible Genomics



Take control of your vision

Age-Related Macular Degeneration (AMD) affects 11 million Americans. 70% of the cause of AMD is due to genetics. This puts 20 million Americans at risk of AMD due to Family History.

Our genetic tests can help you better understand your risk of AMD.

What is the Visible Genomics AMD Risk Assessment?

                                                                                                                                          Visible Genomics now provides you with state-of-the-art clinical-grade AMD risk screening.
Visible Genomics’ AMD risk assessment is a comprehensive test that helps determine whether you are at risk of either developing AMD or progressing to late-stage AMD if you already have signs or symptoms of the disease.

 We combine a patient’s genetic status, ocular findings, demographic and behavior characteristics to deliver an accurate, reliable and clinically actionable AMD risk assessment.

Knowing this information can help you and your eye doctor take a proactive personalized approach to prevent or delay AMD.

Order your test TODAY!